<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:43:33Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8948530" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8948530</identifier>
        <datestamp>2022-04-11</datestamp>
        <setSpec>jamasd</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id>
              <journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id>
              <journal-title-group>
                <journal-title>JAMA Network Open</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2574-3805</issn>
              <publisher>
                <publisher-name>American Medical Association</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8948530</article-id>
              <article-id pub-id-type="pmcid">PMC8948530</article-id>
              <article-id pub-id-type="pmc-uid">8948530</article-id>
              <article-id pub-id-type="pmid">35323953</article-id>
              <article-id pub-id-type="pmid">35323953</article-id>
              <article-id pub-id-type="doi">10.1001/jamanetworkopen.2022.4050</article-id>
              <article-id pub-id-type="publisher-id">zld220038</article-id>
              <article-categories>
                <subj-group subj-group-type="category" specific-use="electronic">
                  <subject>Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Research Letter</subject>
                </subj-group>
                <subj-group subj-group-type="online-only">
                  <subject>Online Only</subject>
                </subj-group>
                <subj-group subj-group-type="subject-area">
                  <subject>Statistics and Research Methods</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effect of Partial vs Full Disclosure of Potential Assignment to Placebo on Participant Blinding, Perceptions of Group Assignment, and Trial Outcomes</article-title>
                <subtitle>A Randomized Clinical Trial</subtitle>
                <alt-title alt-title-type="headline">Effect of Placebo Information Disclosure on Participant Blinding and Outcomes</alt-title>
                <alt-title alt-title-type="running-head">Effect of Placebo Information Disclosure on Participant Blinding and Outcomes</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Won</surname>
                    <given-names>Jiyoon</given-names>
                  </name>
                  <degrees>KMD</degrees>
                  <degrees>MSc</degrees>
                  <xref rid="zld220038aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bang</surname>
                    <given-names>Heejung</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zld220038aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Lee</surname>
                    <given-names>Hyangsook</given-names>
                  </name>
                  <degrees>KMD</degrees>
                  <degrees>PhD</degrees>
                  <xref rid="zld220038aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="zld220038aff1"><label>1</label>Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, Seoul</aff>
              <aff id="zld220038aff2"><label>2</label>Division of Biostatistics, Department of Public Health Sciences, University of California, Davis</aff>
              <author-notes>
                <title>Article Information</title>
                <p><bold>Accepted for Publication:</bold> February 6, 2022.</p>
                <p content-type="published-online"><bold>Published:</bold> March 24, 2022. <?xpp bx;1?>doi:<uri content-type="doi">10.1001/jamanetworkopen.2022.4050</uri></p>
                <p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. Â© 2022 Won J et al. <italic>JAMA Network Open</italic>.</p>
                <corresp id="zld220038cor1"><bold>Corresponding Author:</bold> Hyangsook Lee, KMD, PhD, Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, 26 Kyung Hee Dae-ro, Dongdaemun-gu, Seoul 02447, Korea (<email xlink:href="erc633@khu.ac.kr">erc633@khu.ac.kr</email>).</corresp>
                <p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Won and Lee had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</p>
                <p><italic>Concept and design:</italic> Lee.</p>
                <p><italic>Acquisition, analysis, or interpretation of data:</italic> All authors.</p>
                <p><italic>Drafting of the manuscript:</italic> Won.</p>
                <p><italic>Critical revision of the manuscript for important intellectual content:</italic> Bang and Lee.</p>
                <p><italic>Statistical analysis:</italic> Won.</p>
                <p><italic>Obtained funding:</italic> Lee.</p>
                <p><italic>Administrative, technical, or material support:</italic> Lee.</p>
                <p><italic>Supervision:</italic> Bang and Lee.</p>
                <p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> None reported.</p>
                <p content-type="funding-statement"><bold>Funding/Support:</bold> This work was supported by grants NRF-2017R1A2B4006407 and NRF-2020R1A6A6017334 from the National Research Foundation of Korea funded by the Korean Ministry of Science and Information and Communication Technology (Dr Lee). This research was partly supported by grant UL1-TR001860 from the National Institutes of Health (Dr Bang).</p>
                <p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p>
                <p><bold>Trial Registration:</bold> ClinicalTrials.gov Identifier: <ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT04182295" ext-link-type="uri">NCT04182295</ext-link></p>
                <p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-ZLD220038-1-s" ref-type="supplementary-material">Supplement 3</xref>.</p>
                <p><bold>Additional Contributions:</bold> We thank Phillip Pfeifer, PhD, BSIE (retired from University of Virginia), for valuable comments on our manuscript. Paid editorial assistance was provided by Caron Modeas (Evolved Editing LLC).</p>
              </author-notes>
              <pub-date pub-type="epub" iso-8601-date="2022-03-24T10:00">
                <day>24</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>24</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>5</volume>
              <issue>3</issue>
              <elocation-id>e224050</elocation-id>
              <history>
                <date date-type="received">
                  <day>21</day>
                  <month>10</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>6</day>
                  <month>2</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright 2022 Won J et al. <italic>JAMA Network Open</italic>.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf-version" xlink:href="jamanetwopen-e224050.pdf">jamanetwopen-e224050.pdf</self-uri>
              <self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.4050"/>
              <abstract abstract-type="teaser" specific-use="electronic">
                <p>This randomized clinical trial investigates the effect of partial vs full disclosure of potential assignment to placebo on participant blinding, perceptions of group assignment, and clinical outcomes.</p>
              </abstract>
            </article-meta>
          </front>
          <body>
            <sec id="H1-1-ZLD220038">
              <title>Introduction</title>
              <p>Successful participant blinding in a placebo-controlled randomized clinical trial (RCT) strengthens the credibility of the results, because knowledge of the assignment and perception of the treatment may affect outcomes. During the informed consent process in RCTs, the current standard is to provide full disclosure (FD) regarding the placebo or control selected. However, in some nonpharmacologic trials, partial disclosure (PD) may be used. A review reported that this difference in disclosure (FD vs PD) might affect participant blinding, and the pooled estimate of between-group effect sizes could be larger with PD than FD.<sup><xref rid="zld220038r1" ref-type="bibr">1</xref></sup> Studies that directly compare different placebo information disclosures are lacking. Therefore, we tested the effect of FD vs PD on participant blinding and clinical outcomes of acupuncture and delayed-onset muscle soreness.</p>
            </sec>
            <sec id="H1-2-ZLD220038">
              <title>Methods</title>
              <p>This RCT was approved by the Kyung Hee University Ethics Committee (trial protocol appears in <xref rid="note-ZLD220038-1-s" ref-type="supplementary-material">Supplement 1</xref>). Volunteers provided written informed consent. The trial followed the Consolidated Standards of Reporting Trials (<ext-link xlink:href="https://www.equator-network.org/reporting-guidelines/consort/" ext-link-type="uri">CONSORT</ext-link>) guideline.</p>
              <p>The trial was conducted from October to December 2019. Participant recruitment is described in eAppendix 1 of <xref rid="note-ZLD220038-1-s" ref-type="supplementary-material">Supplement 2</xref>; randomization is shown in the <xref rid="zld220038f1" ref-type="fig">Figure</xref>. In total, 89 healthy adult volunteers were randomized to 1 of 4 groups: real acupuncture (RA) and FD, RA and PD, placebo acupuncture (PA) and FD, and PA and PD. The patient information leaflet (PIL) for the FD group stated that control acupuncture is simulated acupuncture; the PIL for the PD group stated that control acupuncture has been used in clinical trials as a comparison to experimental acupuncture. The study description provided to patients and all procedures are described in eAppendix 1 in <xref rid="note-ZLD220038-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p>
              <fig position="float" id="zld220038f1" fig-type="figure">
                <label>Figure. </label>
                <caption>
                  <title>Study Flow Diagram</title>
                </caption>
                <graphic xlink:href="jamanetwopen-e224050-g001" position="float"/>
              </fig>
              <p>Delayed-onset muscle soreness was induced on the biceps brachii of the nondominant arm with eccentric exercise (eAppendix 2 in <xref rid="note-ZLD220038-1-s" ref-type="supplementary-material">Supplement 2</xref>). The allocated acupuncture treatment was given, and pain and discomfort were assessed once daily for 3 days using an algometer and a visual analog scale. Placebo acupuncture was identical to RA except that nonpenetrating acupuncture needles replaced actual needles (eAppendix 3, eFigure in <xref rid="note-ZLD220038-1-s" ref-type="supplementary-material">Supplement 2</xref>).<sup><xref rid="zld220038r2" ref-type="bibr">2</xref></sup> On day 3, participants were debriefed about the study hypothesis and their acupuncture assignment.</p>
              <p>The primary outcome, blinding property, was measured with a blinding index (BI), calculated as the difference in the estimated probabilities of correct vs incorrect guesses (&gt;0 [null] indicate a more correct guess). For interpretation, the BI values were categorized as more correct (â¥0.2), random (â0.2 &lt; BI &lt; 0.2), or incorrect (â¤â0.2) and another ideal blinding (â0.2 &lt; summed BI &lt; 0.2).<sup><xref rid="zld220038r3" ref-type="bibr">3</xref>,<xref rid="zld220038r4" ref-type="bibr">4</xref></sup></p>
              <p>The BI was calculated and blinding scenarios were descriptively interpreted,<sup><xref rid="zld220038r3" ref-type="bibr">3</xref>,<xref rid="zld220038r4" ref-type="bibr">4</xref></sup>and pain and discomfort data were subjected to mixed analysis of variance with a significance level at <italic>P</italic> &lt; .05 (2-sided). All statistical analyses were performed with SPSS, version 25.0 (IBM).</p>
            </sec>
            <sec id="H1-3-ZLD220038">
              <title>Results</title>
              <p>Of 89 participants, 40 were men and 49 were women (<xref rid="zld220038f1" ref-type="fig">Figure</xref>). Participants had a mean (SD) age of 26.6 (8.7) years. In both RA groups, the assignment guess was more likely to be correct regardless of the placebo disclosure degree; 13 (45%) and 11 (35%) participants in the RA-FD and RA-PD groups were more likely to guess their group assignment as RA beyond chance (BI, 0.45 [95% CI, 0.15 to 0.76]) and 0.35 [95% CI, 0.06 to 0.63], respectively). In contrast, 11 (36%) PA-PD recipients were more likely to believe they received RA vs 9 (14%) PA-FD recipients (incorrect guess; BI, â0.36 [95% CI, â0.66 to â0.07] and â0.14 [95% CI, â0.48 to 0.20], respectively). The blinding scenario under FD of placebo information might be interpreted as possibly problematic (RA: correct guess; PA: random guess) and that of PD ideal (RA: correct guess; PA: opposite guess), resulting in a summed BI value of â0.01âââ0 (<xref rid="zld220038t1" ref-type="table">Table</xref>).<sup><xref rid="zld220038r5" ref-type="bibr">5</xref></sup></p>
              <table-wrap position="float" id="zld220038t1">
                <label>Table. </label>
                <caption>
                  <title>Blinding Index Values for Treatment Assignment and Placebo Disclosure Status of 89 Participants</title>
                </caption>
                <table frame="hsides" rules="groups">
                  <col width="10.16%" span="1"/>
                  <col width="9.32%" span="1"/>
                  <col width="9.32%" span="1"/>
                  <col width="9.32%" span="1"/>
                  <col width="15.26%" span="1"/>
                  <col width="8.29%" span="1"/>
                  <col width="15.44%" span="1"/>
                  <col width="22.89%" span="1"/>
                  <thead>
                    <tr>
                      <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Group assignment</th>
                      <th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">Guess, No. of participants (%)</th>
                      <th rowspan="2" valign="top" align="left" scope="col" colspan="1">BI (95% CI)<xref rid="zld220038t1n1" ref-type="table-fn"><sup>a</sup></xref></th>
                      <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Summed BI<xref rid="zld220038t1n2" ref-type="table-fn"><sup>b</sup></xref></th>
                      <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Blinding status/scenario</th>
                      <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Possible blinding effectiveness interpretations<xref rid="zld220038t1n3" ref-type="table-fn"><sup>c</sup></xref></th>
                    </tr>
                    <tr>
                      <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Acupuncture</th>
                      <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Placebo</th>
                      <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Do not know</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Full disclosure</td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="middle" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">âAcupuncture</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">13 (59)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">3 (14)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">6 (27)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0.45 (0.15 to 0.76)</td>
                      <td rowspan="2" valign="middle" align="left" colspan="1">0.31</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">More correct guess</td>
                      <td rowspan="2" valign="top" align="left" colspan="1">Possibly problematic; there was a perceived treatment effect in the acupuncture group, whereas there was no significant effect in the placebo group (eg, placebo group participants may not have wishful thinking in the absence of a treatment effect)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">âPlacebo</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">9 (41)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">6 (27)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">7 (32)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">â0.14 (â0.48 to 0.20)</td>
                      <td valign="top" colspan="1" align="left" rowspan="1">Random guess</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Partial disclosure</td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="middle" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">âAcupuncture</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">11 (48)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">3 (13)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">9 (39)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0.35 (0.06 to 0.63)</td>
                      <td rowspan="2" valign="middle" align="left" colspan="1">â0.01</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">More correct guess</td>
                      <td rowspan="2" valign="top" align="left" colspan="1">Ideal; both groups tend to believe they received real acupuncture (eg, participants tend to have strong wishful thinking, or placebo as well as real acupuncture is perceived as a real treatment)</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">âPlacebo</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">11 (50)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">3 (14)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">8 (36)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">â0.36 (â0.66 to â0.07)</td>
                      <td valign="top" colspan="1" align="left" rowspan="1">Opposite guess</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">44 (49)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">15 (17)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">30 (34)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <p>Abbreviations: BI, blinding index; NA, not applicable.</p>
                  <fn id="zld220038t1n1">
                    <label>
                      <sup>a</sup>
                    </label>
                    <p>The BI is a chance-corrected measure of potential unblinding via a proxy for disproportionate correct guesses in a group. The BI is used to calculate the index value and then to possibly categorize blinding scenarios (using conventional, ad hoc cut points) as more correct (â¥0.2), random (â0.2 &lt; BI &lt; 0.2), or more incorrect (â¤â0.2) and another ideal blinding (â0.2 &lt; summed BI &lt; 0.2).</p>
                  </fn>
                  <fn id="zld220038t1n2">
                    <label>
                      <sup>b</sup>
                    </label>
                    <p>The summed BI (acupuncture group plus placebo group) measures the difference in proportions with the same guess. For values ofâ0, an equal proportion of participants in both groups believed they had received real acupuncture (more commonly) or placebo (less commonly), implying so-called wishful thinking (or negative thinking for placebo, which is less common). For values greater than 0, more participants in the acupuncture group believed that they had received acupuncture than those in the placebo group.</p>
                  </fn>
                  <fn id="zld220038t1n3">
                    <label>
                      <sup>c</sup>
                    </label>
                    <p>A value of 0 for either BI in both active and placebo groups or summed BI indicates the 2 most ideal blinding scenarios, implying a random guess or wishful thinking (as a metaphor for common representative scenarios), respectively.<sup><xref rid="zld220038r4" ref-type="bibr">4</xref>,<xref rid="zld220038r5" ref-type="bibr">5</xref></sup> If both groups guessed they were receiving active treatment in equal proportions, blinding could be a success.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>There were no significant between-group differences in pain and discomfort at any time point (all <italic>P</italic>ââ¥â.26). After debriefing, most participants accepted the study hypothesis, design, and overall procedures.</p>
            </sec>
            <sec id="H1-4-ZLD220038">
              <title>Discussion</title>
              <p>In the informed consent process, differently disclosed information about the placebo control has led to different blinding scenarios. Although research on this topic is scarce in RCT communities, how placebo information is disclosed in PILs may possibly influence participant blinding. Limitations of this study include its small sample size, the short-term trial length with an acute condition, and participantsâ understanding and recollection of PILs possibly affected by other factors.</p>
              <p>Given that PD was acceptable to most participants, further investigation is warranted to identify best practices regarding placebo disclosure to inform participants about placebo without jeopardizing their autonomy, while securing blinding and retention or adherence to ensure study rigor and validity. It would be interesting to see how these findings are translated into other medical disciplines.</p>
            </sec>
          </body>
          <back>
            <ref-list id="REF-ZLD220038">
              <title>References</title>
              <ref id="zld220038r1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Cheon</surname><given-names>S</given-names></string-name>, <string-name><surname>Park</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Chae</surname><given-names>Y</given-names></string-name>, <string-name><surname>Lee</surname><given-names>H</given-names></string-name></person-group>. <article-title>Does different information disclosure on placebo control affect blinding and trial outcomes? a case study of participant information leaflets of randomized placebo-controlled trials of acupuncture</article-title>. <source>BMC Med Res Methodol</source>. <year>2018</year>;<volume>18</volume>(<issue>1</issue>):<fpage>13</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12874-018-0474-1</pub-id><?supplied-pmid 29347917?><pub-id pub-id-type="pmid">29347917</pub-id></mixed-citation>
              </ref>
              <ref id="zld220038r2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Park</surname><given-names>J</given-names></string-name>, <string-name><surname>White</surname><given-names>A</given-names></string-name>, <string-name><surname>Lee</surname><given-names>H</given-names></string-name>, <string-name><surname>Ernst</surname><given-names>E</given-names></string-name></person-group>. <article-title>Development of a new sham needle</article-title>. <source>Acupunct Med</source>. <year>1999</year>;<volume>17</volume>(<issue>2</issue>):<fpage>110</fpage>-<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.1136/aim.17.2.110</pub-id></mixed-citation>
              </ref>
              <ref id="zld220038r3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Bang</surname><given-names>H</given-names></string-name>, <string-name><surname>Ni</surname><given-names>L</given-names></string-name>, <string-name><surname>Davis</surname><given-names>CE</given-names></string-name></person-group>. <article-title>Assessment of blinding in clinical trials</article-title>. <source>Control Clin Trials</source>. <year>2004</year>;<volume>25</volume>(<issue>2</issue>):<fpage>143</fpage>-<lpage>156</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cct.2003.10.016</pub-id><?supplied-pmid 15020033?><pub-id pub-id-type="pmid">15020033</pub-id></mixed-citation>
              </ref>
              <ref id="zld220038r4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Moroz</surname><given-names>A</given-names></string-name>, <string-name><surname>Freed</surname><given-names>B</given-names></string-name>, <string-name><surname>Tiedemann</surname><given-names>L</given-names></string-name>, <string-name><surname>Bang</surname><given-names>H</given-names></string-name>, <string-name><surname>Howell</surname><given-names>M</given-names></string-name>, <string-name><surname>Park</surname><given-names>JJ</given-names></string-name></person-group>. <article-title>Blinding measured: a systematic review of randomized controlled trials of acupuncture</article-title>. <source>Evid Based Complement Alternat Med</source>. <year>2013</year>;<volume>2013</volume>:<elocation-id>708251</elocation-id>. doi:<pub-id pub-id-type="doi">10.1155/2013/708251</pub-id><?supplied-pmid 23533515?><pub-id pub-id-type="pmid">23533515</pub-id></mixed-citation>
              </ref>
              <ref id="zld220038r5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Freed</surname><given-names>B</given-names></string-name>, <string-name><surname>Williams</surname><given-names>B</given-names></string-name>, <string-name><surname>Situ</surname><given-names>X</given-names></string-name>, <etal/></person-group>. <article-title>Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000-2019: a review and meta-analytic approach</article-title>. <source>Clin Trials</source>. <year>2021</year>;<volume>18</volume>(<issue>3</issue>):<fpage>361</fpage>-<lpage>370</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1740774520984870</pub-id><?supplied-pmid 33478258?><pub-id pub-id-type="pmid">33478258</pub-id></mixed-citation>
              </ref>
            </ref-list>
            <notes notes-type="supplementary-material" id="note-ZLD220038-1">
              <supplementary-material id="note-ZLD220038-1-s" position="float" content-type="local-data">
                <label>Supplement 1.</label>
                <caption>
                  <p>
Trial Protocol
</p>
                </caption>
                <media xlink:href="jamanetwopen-e224050-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material position="float" content-type="local-data">
                <label>Supplement 2.</label>
                <caption>
                  <p><bold>eAppendix 1.</bold> Study Procedures</p>
                  <p><bold>eAppendix 2.</bold> Induction of Delayed-Onset Muscle Soreness and Outcome Measurement</p>
                  <p><bold>eAppendix 3.</bold> Acupuncture Protocol</p>
                  <p><bold>eFigure.</bold> Study Procedures</p>
                </caption>
                <media xlink:href="jamanetwopen-e224050-s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material position="float" content-type="local-data">
                <label>Supplement 3.</label>
                <caption>
                  <p>
Data Sharing Statement
</p>
                </caption>
                <media xlink:href="jamanetwopen-e224050-s003.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </notes>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
